Sorry, we do not have enough data to show an influence graph for this author.
The efficacy of prolonged use of the cytoprotective neuropeptide Cortexin on cognitive impairments was studied in patients with ischemic stroke. A total of 80 patients with first ischemic strokes were studied. Patients of the study group (n = 40) received basal treatment plus 10 mg i.m. Cortexin once daily for 10 days, with repeat courses given at three,… (More)